MLTXMoonLake Immunotherapeutics
MLTX
MoonLake Immunotherapeutics4,996
Mkt Cap
$1.04BVolume
2.24M52W High
$62.7552W Low
$5.95PE Ratio
-4.23MLTX Fundamentals
Price
$14.07Prev Close
$14.61Open
$14.4450D MA
$11.36Beta
0.51Avg. Volume
2.21MEPS (Annual)
-$1.89P/B
3.10Rev/Employee
$0.00Kristian Reich Sells 130,000 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) insider Kristian Reich sold 130,000 shares of the company's stock in a transaction dated Monday, December 8th. The shares were sold at an...
MarketBeat·6h ago
MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Sells $1,960,400.00 in Stock
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 130,000 shares of the stock in a transaction dated Monday, December 8th. The stock was sold at an average...
MarketBeat·6h ago
MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 70,000 Shares
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 70,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 9th. The stock was...
MarketBeat·6h ago
MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Kristian Reich Sells 72,908 Shares
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) insider Kristian Reich sold 72,908 shares of the stock in a transaction dated Tuesday, December 9th. The shares were sold at an average...
MarketBeat·6h ago
DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025
DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025 DEADLINE NEXT WEEK: Berger Montague Advises MoonLake...
PR Newswire·14h ago
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
Global plaintiffs' rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) is rapidly...
Business Wire·2d ago
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman MLTX 6-DAY...
PR Newswire·2d ago
Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX Investors in MoonLake Immunotherapeutics Should Contact Levi...
PR Newswire·3d ago
Marshall Wace LLP Sells 111,706 Shares of MoonLake Immunotherapeutics $MLTX
Marshall Wace LLP reduced its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) by 17.4% in the second quarter, according to the company in its most recent 13F filing with...
MarketBeat·3d ago
Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX)
Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action...
PR Newswire·4d ago